WakeMed Health and Hospitals is a 919-bed healthcare system with multiple facilities placed around the metropolitan Raleigh, North Carolina area. WakeMed's main campus is located on New Bern Avenue in Raleigh, North Carolina.

During the past decade, WakeMed conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 18 clinical trials were completed, i.e. on average, 36% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 9 clinical trials were completed. i.e. 40.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WakeMed" #1 sponsor was "Boston Scientific Corporation" with 25 trials, followed by "Abbott Medical Devices" with 10 trials sponsored, "Duke University" with 6 trials sponsored, "Medtronic" with 6 trials sponsored and "University of North Carolina, Chapel Hill" with 6 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WakeMed" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "Duke Clinical Research Institute" with 4 trials as a collaborator, "Duke University" with 3 trials as a collaborator, "University of North Carolina, Chapel Hill" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 101 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "WakeMed" are "Coronary Artery Disease" (27 trials), "Heart Failure" (13 trials), "Atherosclerosis" (6 trials), "Coronary Artery Stenosis" (4 trials) and "Myocardial Ischemia" (4 trials). Many other conditions were trialed in "WakeMed" in a lesser frequency.

Most popular intervention types in "WakeMed" are "Device" (52 trials), "Drug" (19 trials), "Other" (10 trials), "Procedure" (7 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "PROMUS Element Coronary Stent System" (3 trials), "TAXUS Liberté-SR" (3 trials), "Absorb BVS" (2 trials) and "Aspirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "WakeMed" are 87 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "WakeMed". undefined are not yet recruiting, 13 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in WakeMed, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in WakeMed, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 36 trials that are defined as “Not Applicable".

WakeMed has several departments that took part in Clinical trials: "WakeMed Heart and Vascular" - 6 trials, "Wake Urological Associates" - 3 trials, "WakeMed Bariatric Specialists of North Carolina" - 2 trials